PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results

[ad_1]

  • Net new business of $872.4 million in the fourth quarter excluding reimbursement revenue; representing growth of 32.4%; Net book-to-bill of 1.42
  • Net new business of $1,437.8 million in the fourth quarter including reimbursement revenue; representing growth of 58.4%; Net book-to-bill of 1.80
  • $873.5 million of total revenue in the fourth quarter; representing growth of 9.1% at actual foreign exchange rates and 8.0% on a constant currency basis
  • Fourth quarter GAAP net income per diluted share of…

[ad_2]